Abstract
Transforming growth factor-β (TGF-β) is an important regulator of cellular growth and immune homeostasis (1–3). TGFβ is a homodimeric 25-kDa protein which activates cellular signaling through the recruitment and transphos-phorylation of specific heterodimeric cell-surface receptors (4). Although activation of TGF-β receptors initiates serine/threonine kinase activity, the subsequent signaling mechanisms involved in a wide array of diverse functional consequences is currently under investigation. TGF-β has been postulated to play important roles in tissue fibrosis and the regulation of the extracellular matrix (5), growth arrest of epithelial cells (6), regulation of the immune response, and induction of apoptotic cell death (7–11). The essential nature of this cytokine is exemplified by the lethal and nonoverlapping phenotypes of the three highly homologous mammalian TGF-β isoforms, each of which exhibit cell-specific expression (3,12). TGF-β1 deficient mice exhibit extensive lymphocytic hyperproliferation and the production of autoimmune antibodies found in several human diseases (3,13–16).
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Hocevar B. A. and Howe P. H. (1988) Mechanisms of TGFβ-induced cell cycle arrest. Miner. Electrolyte Metab. 24, 131–135.
Roberts A. B. (1998) Molecular and cellular biology of TGFβ. Miner. Electrolyte Metab. 24, 111–119.
Letterio J. J. and Böttinger E. P. (1998) TGFβ knockout and Dominant negative receptor transgenic mice. Miner. Electrolyte Metab. 24, 161–167.
Massagué J., Attiasno L., and Wrana J. L. (1994) The TGF-β family and its composite receptors. Trends Cell Biol. 4, 172–177.
Hines K. L., Kulkarni A. B., McCarthy J. B., Tian H., Ward J. M., Christ M., McCartney-Francis N. L., Furcht L. T., Karlsson S., and Wahl S. M. (1994) Synthetic fibronectin peptides interrupt inflammatory cell infiltration in transforming growth factor beta 1 knockout mice. Proc. Natl. Acad. Sci. USA 91, 5187–5191.
Howe P. H., Draetta G., and Leof E. B. (1991) Transforming growth factor beta 1 inhibition of p34cdc2 phosphorylation and histone H1 kinase activity is associ ated with G1/S-phase growth arrest. Mol. Cell. Biol. 11, 1185–1194.
Brown T. L., Patil S., Basnett R. K., and Howe P. H. (1998) Caspase inhibitor BD-fmk distinguishes transforming growth factor β-induced apoptosis from growth inhibition. Cell Growth Differ. 9, 869–875.
Brown T. L., Patil S., Cianci C. D., Morrow J. S., and Howe P. H. (1999) TGFp induces caspase 3 independent cleavage of aII spectrin (α-fodrin) coincident with apoptosis. J. Biol. Chem. 274, 23,256–23,262.
Fischer G., Kent S. C., Joseph L., Green D. R., and Scott D. W. (1994) Lymphoma models for B cell activation and tolerance. X. Anti-mu-mediated growth arrest and apoptosis of murine B cell lymphomas is prevented by the stabilization of myc. J. Exp. Med. 179, 221–228.
Warner G. L., Ludlow J. W., Nelson D. A., Gaur A., and Scott D. W. (1992) Anti-immunoglobulin treatment of murine B-cell lymphomas induces active transforming growth factor beta but pRB hypophosphorylation is transforming growth factor beta independent. Cell Growth Differ. 3, 175–181.
Arsura M., Wu M., and Sonenshein G. E. (1996) TGF beta 1 inhibits NF-kappa B/Rel activity inducing apoptosis of B cells: transcriptional activation of I kappa B alpha. Immunity 5, 31–40.
Shull M. M., Ormsby I., Kier A. B., Pawlowski S., Diebold R. J., Yin M., Allen R., Sidman C., Proetzel G., Calvin D., Annunziation N., and Doetschman T. (1992) Targeted disruption of the mouse transforming growth factor beta 1 gene results in multifocal inflammatory disease. Nature 359, 693–699.
Diebold R. J., Eis M. J., Yin M., Ormsby I., Boivin G. P., Darrow B. J., Saffitz J. E., and Doetschman T. (1995) Early onset multifocal inflammation in the transforming growth factor beta 1 null mouse is lymphocyte mediated. Proc. Natl. Acad. Sci. USA 92, 12,215–12,219.
Christ M. McCartney-Francis N. L., Kulkarni A. B., Ward J. M., Mizel D. E., Mackall C. L., Gress R. E., Hines K. L., Tian H., Karlsson S., and Wahl S. M. (1994) Immune dysregulation in TGFβ 1 deficient mice. J. Immunol. 153, 1936–1946.
Dang H., Geiser A. G., Letterio J. J., Nakabayashi T., Kong L., Fernandes G., and Talal N. (1995) SLE-like autoantibodies and Sjögren’s syndrome-like lymphoproliferation in TGFβl knockout mice. J. Immunol. 155, 3205–3212.
Yaswen L., Kulkarni A. B., Fredrickson T., Mittlemab B., Schiffmann R., Payne S., Longenecker G., Mozes E., and Karlsson S. (1996) Autoimmune manifestations in the transforming growth factor beta-1 knockout mouse. Blood 87, 1439–1445.
Gottschalk A. R. and Quintans J. (1995) Apoptosis in B lymphocytes: the WEHI-231 perspective. Immunol Cell Biol. 73, 8–16.
Lee J. R. and Koretzky G. A. (1998) Extracellular signal-regulated kinase-2, but not c-Jun NH2-terminal kinase, activation correlates with surface IgM-mediated apoptosis in the WEHI 231 B cell line. J Immunol. 161, 1637–1644.
Fang W., Rivard J. J., Ganser J. A., LeBien T. W., Nath K. A., Mueller D. L., and Behrens T. W. (1995) Bcl—xL rescues WEHI 231 B lymphocytes from oxidant-mediated death following diverse apoptotic stimuli. J. Immunol. 155, 66–75.
Chen L., Kim T. J., and Pillai S. (1998) Inhibition of caspase activity prevents anti-IgM induced apoptosis but not ceramide generation in WEHI 231 B cells. Mol. Immunol. 35, 195–205.
Ezhevsky S. A., Toyoshima H., Hunter T., and Scott D. W. (1996) Role of Cyclin A and p27 in anti-IgM-induced G1 growth arrest of murine B-cell lymphomas. Mol. Biol. Cell 7, 553–564.
Ewen M. E., Sluss H. K., Whitehouse L. L., and Livingston D. M. (1993) TGFβ inhibition of cdk4 synthesis is linked to cell cycle arrest. Cell 74, 1009–1020.
Chen R.-H. and Chang T.-Y. (1997) Involvement of caspase family proteases in transforming growth factor-β-induced apoptosis. Cell Growth Differ. 8, 821–827.
Selvakumaran M., Lin H.-K., Sjin R. T., Reed J. C., Lieberman D. A., and Hoffman B. (1994) The novel primary response gene Myd1 18 and the protooncogenes myb, myc, and bcl-2 modulate transforming growth factor-β-induced apoptosis of myeloid leukemia cells Mol. Cell. Biol. 14, 2352–2360.
Rotello R. J., Liebermann R. C., Purchio A. F., and Gerschenson L. E. (1991) Coordinated regulation of apoptosis and cell proliferation by transforming growth factor-β1 in cultured uterine epithelial cells. Proc. Natl. Acad. Sci. USA 88, 3412–3415.
Moulton B. C., Akcali K. C., Ogle T. F., Brown T. L., Motz J., and Khan S. A. (1977) Control of apoptosis in the uterus during decidualization in Cell Death in Reproductive Physiology (Tilly J. L., Strauss J. F., III, and Tenniswood M., eds.), Springer-Verlag, New York, pp. 48–66.
Oberhammer F. A., Pavelka M., Sharma S., Tiefenbacher R., Purchio A. F., Bursch W., and Schulte-Hermann R. (1992) Induction of apoptosis in cultured hepatocytes and in regressing liver by transforming growth factor-β. Proc. Natl. Acad. Sci. USA 89, 5408–5412.
Fukuda K., Kojiro M., and Chiu J.-F. (1993) Induction of apoptosis by transforming growth factor-βl in the rat hepatoma cell line McA-RH7777: a possible association with tissue transglutaminase expression. Hepatology 18, 945–952.
Lin J.-K. and Chou C.-K. (1992) In vitro apoptosis in the human hepatoma cell line induced by transforming growth factor-β1. Cancer Res. 52, 385–388
Chuang L.-Y., Hung W.-C., Chang C.-C., and Tsai J.-H. (1994) Characterization of apoptosis induced by transforming growth factor-β1 in human hepatoma cells. Anticancer Res. 14, 147–152.
Choi K. S., Lim I. K., Brady J. N., and Kim S.-J. (1998) Ice-like protease (Caspase) is involved in transforming growth factor-β1-mediated apoptosis in FaO rat hepatoma cell line. Hepatology 27, 415–421.
Vaux D. L. and Strasser A. (1996) The molecular biology of apoptosis. Proc. Natl. Acad. Sci. USA 93, 2239–2244.
Salvesen G. S. and Dixit V. M. (1997) Caspases: intracellular signaling by proteolysis. Cell 91, 443–446.
Cohen G. M. (1997) Caspases: the executioners of apoptosis. Biochem. J. 326, 1–16.
Morrow J. S., Rimm D. L., Kennedy S. P., Cianci C. D., Sinard J. H., and Weed S. A. (1997) Of membrane stability and mosaics: the spectrin cytoskeleton, in Handbook of Physiology (Hoffman J. and Jamieson J., eds.), Oxford University Press, London, pp. 485–540.
Wang K. W., Posmantur R., Nath R., McGinnis K., Whitton M., Talanian R. V., Glantz S. B., and Morrow J. S. (1998) Simultaneous degradation of α and βII spectrin by caspase 3 (cpp32) in apoptotic cells. J. Biol. Chem. 273, 22,490–22,497.
Janicke R. U., Ng P., Sprengart M. L., and Porter A. G. (1998) Caspase 3 is required for α-fodrin cleavage but dispensable for cleavage of other death substrates in apoptosis. J. Biol. Chem. 273, 15,540–15,545.
Martin S. J., O’Brien G. A., Nishioka W. K., McGahon A. J., Mahboubi A., Saido T. C., and Green D. R. (1995) Proteolysis of fodrin (non-erythroid spectrin) during apoptosis. J. Biol. Chem. 270, 6425–6428.
Nath R., Raser K. J., Stafford D., Hajimohammadreza I., Posner A., Allen H., Talanian R. V., Yuen P., Gilbertsen R. B., and Wang K. W. (1996) Non-erythroid α-spectrin breakdown by calpain and interleukinl β-converting-enzyme-like protease(s) in apoptotic cells: contributory roles of both protease families in neuronal apoptosis. Biochem. J. 319, 683–690.
Cryns V. L., Bergeron L., Zhu H., Li H., and Yuan J. (1996) Specific cleavage of α-fodrin during fas and tumor necrosis factor-induced apoptosis is mediated by an interleukin-1 β-converting enzyme/Ced-3 protease distinct from the poly(ADP-ribose) polymerase protease. J. Biol. Chem. 271, 31,277–31,282.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2000 Humana Press Inc.
About this protocol
Cite this protocol
Brown, T.L., Patil, S., Howe, P.H. (2000). Analysis of TGFβ-Inducible Apoptosis. In: Howe, P.H. (eds) Transforming Growth Factor-Beta Protocols. Methods in Molecular Biology™, vol 142. Humana Press. https://doi.org/10.1385/1-59259-053-5:149
Download citation
DOI: https://doi.org/10.1385/1-59259-053-5:149
Publisher Name: Humana Press
Print ISBN: 978-0-89603-646-8
Online ISBN: 978-1-59259-053-7
eBook Packages: Springer Protocols